Birdwatch Archive

Birdwatch Note Rating

2024-01-15 09:42:20 UTC - NOT_HELPFUL

Rated by Participant: 10FAB9B553518A9C6FFF9ACB0373C54E1E985EDAFFB8BA79AFE01136B1B18727
Participant Details

Original Note:

Notzulassung ist falsch. Bedingte Zulassung ist übliches Vorgehen bei Erstzulassungen. "Die EU-Kommission hat am 28. Januar 2022 eine bedingte Zulassung für das orale antivirale Arzneimittel Paxlovid® (Nirmatrelvir + Ritonavir) zur Behandlung von COVID-19 erteilt." https://www.bfarm.de/DE/Arzneimittel/Arzneimittelinformationen/covid-19-arzneimittel.html

All Note Details

Original Tweet

All Information

  • noteId - 1746801901562126555
  • participantId -
  • raterParticipantId - 10FAB9B553518A9C6FFF9ACB0373C54E1E985EDAFFB8BA79AFE01136B1B18727
  • createdAtMillis - 1705311740026
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 1
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 174680190156212655510FAB9B553518A9C6FFF9ACB0373C54E1E985EDAFFB8BA79AFE01136B1B18727